Regulations.gov document
2024-000121 - Nestle Health Science - Kirkland Signature, CoQ10 300 mg- Maintain Heart…
Other · FDA-2024-S-0024 · posted Feb 21, 2024
Key facts
| Document ID | FDA-2024-S-0024-0011 |
|---|---|
| Title | 2024-000121 - Nestle Health Science - Kirkland Signature, CoQ10 300 mg- Maintain Heart Health |
| Document type | Other |
| Subtype | 30 Day Structured Function Claim |
| Agency | FDA |
| Docket | FDA-2024-S-0024 |
| Posted | Feb 21, 2024 |
| Comment period opens | Feb 21, 2024 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: